You are here: Industry Insights > 2017

News List

Review: Progress of Acceptance Work of Generic Drug Consistency Evaluation in 2017 Erxiao
January 05, 2018
Varieties to be completed the generic drug consistency evaluation be the end of 2018...
46 New Drugs: The Number of New Drugs Marketed in 2017 Set a New Record for Recent 20 Years Dophine
January 03, 2018
FDA approved the marketing of 46 new drugs in total by December 21, 2017, successfully setting a new review record for the recent 20 years.
Four Best Performing S&P 500 Biotech Stocks in 2017 biospace
December 29, 2017
Todd Campbell, writing for The Motley Fool, notes four biopharma stocks that topped out in the S&P 500 in 2017.
5 Milestones Of 2017 In The War On Cancer forbes
December 26, 2017
An impressive 45 novel drugs have been approved by the FDA in 2017 so far — more than doubling last year’s total.
IGMPI wins ASSOCHAM Services Excellence Award 2017 expressbpd
September 01, 2017
IGMPI was felicitated keeping in mind the fundamentally strong and resilient education and knowledge dissemination model
Struggling Endo's write-downs pass $5B for 2017 thanks to Opana, mesh, restructuring fiercepharma
August 09, 2017
In Feburary 2017, Endo took a huge $3.5 billion write-down—but that wouldn’t be just it for the year.
26 Winners recognized at the Asian Scientist Writing Prize 2017 biospectrumasia
July 11, 2017
The top six prizes were handed out by the guest of honor, Minister for Education (Higher Education and Skills), Mr. Ong Ye Kung. The top three winners in the Open category received S$5,000, S$3,000 and S$2,000 in cash prizes.
Prospects of FDA Technical Guidance Work in 2017--Part 2 en-cphi
February 17, 2017
FDA will publish three guidances on biopharmaceutics, Drafts of these three guidances have been issued in 2016, and FDA’s main task for them in 2017 is to gather the industry feedback information and make revisions.
Prospects of FDA Technical Guidance Work in 2017--Part 1 en-cphi
February 17, 2017
FDA, i.e., Food and Drug Administration, the world’s largest regulator of pharmaceutical product market, assumes a large number of management functions, including pharmaceutical product review, inspection, evaluation and supervision, etc.
Seven pharma trends for 2017 pharmafile
January 23, 2017
Perhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation and uncertainty as the industry waits with bated breath in the wake of the two biggest and most indisputable game-changers, not just for pharma, but for the world: Brexit and

Previous page 1 2 Next page